RLMD vs. ANGPY
RLMD (Relmada Therapeutics, Inc.) and ANGPY (Anglo American Platinum ADR) are both stocks. RLMD operates in Biotechnology (Healthcare), while ANGPY operates in Other Precious Metals & Mining (Basic Materials). Over the past 10 years, RLMD returned -3.90%/yr vs 17.46%/yr for ANGPY. At a 0.10 correlation, their price movements are largely independent.
Performance
RLMD vs. ANGPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RLMD achieves a 40.17% return, which is significantly higher than ANGPY's -14.33% return. Over the past 10 years, RLMD has underperformed ANGPY with an annualized return of -3.90%, while ANGPY has yielded a comparatively higher 17.46% annualized return.
RLMD
- 1D
- -1.74%
- 1M
- -3.84%
- YTD
- 40.17%
- 6M
- 50.78%
- 1Y
- 1,008.20%
- 3Y*
- 39.95%
- 5Y*
- -27.28%
- 10Y*
- -3.90%
ANGPY
- 1D
- -2.93%
- 1M
- -10.42%
- YTD
- -14.33%
- 6M
- -18.24%
- 1Y
- 69.55%
- 3Y*
- 19.75%
- 5Y*
- -1.88%
- 10Y*
- 17.46%
RLMD vs. ANGPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RLMD Relmada Therapeutics, Inc. | 40.17% | 828.85% | -87.44% | 18.62% | -84.51% | -29.75% | -17.77% | 747.83% | 53.33% | -31.19% |
ANGPY Anglo American Platinum ADR | -14.33% | 202.15% | -40.10% | -34.38% | -19.08% | 30.87% | 6.85% | 163.52% | 31.10% | 49.21% |
Correlation
The correlation between RLMD and ANGPY is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jun 2, 2016 | 0.10 |
The correlation between RLMD and ANGPY shifts across timeframes, from 0.10 (all time) to 0.22 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
RLMD:
$586.26M
ANGPY:
$18.37B
RLMD:
-$1.06
ANGPY:
ZAR 13.76
RLMD:
2.68
ANGPY:
3.06
RLMD:
$0.00
ANGPY:
ZAR 221.81B
RLMD:
$0.00
ANGPY:
ZAR 45.66B
RLMD:
-$60.34M
ANGPY:
ZAR 50.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RLMD vs. ANGPY — Risk / Return Rank
RLMD
ANGPY
RLMD vs. ANGPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Relmada Therapeutics, Inc. (RLMD) and Anglo American Platinum ADR (ANGPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RLMD | ANGPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +7.33 | ||
| Sortino ratioReturn per unit of downside risk | +4.55 | ||
| Omega ratioGain probability vs. loss probability | 1.68 | 1.20 | +0.48 |
| Calmar ratioReturn relative to maximum drawdown | 37.13 | 1.71 | +35.42 |
| Martin ratioReturn relative to average drawdown | 82.79 | 4.04 | +78.75 |
Loading charts...
Drawdowns
RLMD vs. ANGPY - Drawdown Comparison
The maximum RLMD drawdown since its inception was -99.66%, which is greater than ANGPY's maximum drawdown of -78.47%. Use the drawdown chart below to compare losses from any high point for RLMD and ANGPY.
Loading charts...
Drawdown Indicators
| RLMD | ANGPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.66% | -78.47% | -21.19% |
Max Drawdown (1Y)Largest decline over 1 year | -27.44% | -40.99% | +13.55% |
Max Drawdown (3Y)Largest decline over 3 years | -96.30% | -42.25% | -54.05% |
Max Drawdown (5Y)Largest decline over 5 years | -99.32% | -78.47% | -20.85% |
Max Drawdown (10Y)Largest decline over 10 years | -99.50% | -78.47% | -21.03% |
Current DrawdownCurrent decline from peak | -90.90% | -43.04% | -47.86% |
Average DrawdownAverage peak-to-trough decline | -79.72% | -35.16% | -44.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.29% | 17.28% | -4.99% |
Volatility
RLMD vs. ANGPY - Volatility Comparison
The current volatility for Relmada Therapeutics, Inc. (RLMD) is 16.67%, while Anglo American Platinum ADR (ANGPY) has a volatility of 23.84%. This indicates that RLMD experiences smaller price fluctuations and is considered to be less risky than ANGPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RLMD | ANGPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.67% | 23.84% | -7.17% |
Volatility (6M)Calculated over the trailing 6-month period | 67.81% | 56.29% | +11.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 122.66% | 68.91% | +53.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 116.39% | 58.90% | +57.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 114.21% | 57.11% | +57.10% |
Dividends
RLMD vs. ANGPY - Dividend Comparison
RLMD has not paid dividends to shareholders, while ANGPY's dividend yield for the trailing twelve months is around 3.76%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
ANGPY Anglo American Platinum ADR | 3.76% | 3.87% | 3.40% | 4.85% | 15.62% | 10.20% | 2.91% | 0.99% | 1.11% |
RLMD Relmada Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RLMD vs. ANGPY - Financials Comparison
This section allows you to compare key financial metrics between Relmada Therapeutics, Inc. and Anglo American Platinum ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RLMD and ANGPY have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANGPY has higher volatility (23.84%) compared to RLMD (16.67%). In terms of maximum drawdown, RLMD dropped -99.66% vs ANGPY's -78.47%.
RLMD currently has the higher Sharpe Ratio (8.34 vs 1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RLMD and ANGPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer